What is PHBI stock price today?

PHBI (Pharmagreen Biotech Inc.) stock is trading at $0.00 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is PHBI stock going up or down today?

PHBI stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy PHBI stock now?

The decision to buy PHBI depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is PHBI a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for PHBI based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is PHBI stock overvalued or undervalued?

Use our DCF valuation calculator to determine if PHBI is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is PHBI's P/E ratio?

P/E ratio data for PHBI will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is PHBI's market cap?

PHBI (Pharmagreen Biotech Inc.) has a market capitalization of $0.00 billion, making it a small-cap stock.

What is PHBI's price to book ratio?

Price-to-book ratio for PHBI is available on our dashboard along with other valuation metrics.

Does PHBI pay dividends?

PHBI does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is PHBI's dividend yield?

PHBI does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is PHBI stock a good long-term investment?

PHBI's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is PHBI's revenue growth rate?

PHBI has shown revenue growth of -0.3% over recent periods. Consistent revenue growth is a key indicator of business health and competitive positioning.

Profitability metrics for PHBI are available on our dashboard with complete income statement analysis.

What are the risks of investing in PHBI?

Key risks for PHBI include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does PHBI compare to its competitors?

Compare PHBI to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize PHBI's performance and positioning.

What is PHBI's stock price target for 2026?

Our AI model provides price targets for PHBI based on fundamental analysis: Bull case $0.00 (+30%), Base case $0.00 (+15%), Bear case $0.00 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about PHBI?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for PHBI. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is PHBI's next earnings report?

PHBI reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

PHBI - Pharmagreen Biotech Inc.

NYSE * Healthcare * Drug Manufacturers - Specialty & Generic

$0.00

+$0.00 (+0.00%)

About Pharmagreen Biotech Inc.

Pharmagreen Biotech Inc. operates as a nutraceutical company, engages in the formulating products from blends of therapeutic plants and fungi in North America. The company's primary product is MaxGenomic supplement, a proprietary blend and formulated medicinal mushrooms and medical plants to support the human mind and body. It also provides consulting services for plant genetic selection, tissue culture technologies for starter plantlets production, SOPs for cultivation and live storage of any plant species services. It sells its products through online stores, such as Amazon and Shopify. Pharmagreen Biotech Inc. is headquartered in Coquitlam, Canada.

PHBI Key Statistics

Market Cap

$0.83M

000

Revenue Growth

-0.3%

How PHBI Compares to Peers

PHBI is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

N/A

of 5

Growth Rank

of 6

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
PHBI(This stock)	$829.62K	N/A	-0%	0.0%	-
LLYEli Lilly	$829.71B	40.4	0%	0.3%	vs LLY
JNJJohnson &	$564.35B	21.2	0%	0.2%	vs JNJ
PFEPfizer Inc	$156.77B	20.0	-0%	0.1%	vs PFE
MRKMerck &	$294.39B	16.4	0%	0.3%	vs MRK
ABBVAbbvie Inc	$368.57B	87.6	0%	0.1%	vs ABBV

Pharmagreen Biotech Inc. Company Information

Headquarters: 2987 Blackbear Court, Coquitlam, BC, Canada, V3E 3A2, undefined
Website: www.pharmagreen.ca
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic

Data Updated: April 19, 2026 at 4:23 AM EDT

Ready to invest in PHBI?

Commission-free trading available. Affiliate links.

PHBI Lician Score

5% confidence

4.0/10

Neutral

PHBI has a Lician Score of 4/10 (Average). Areas of concern: Growth.

value

5.0

growth

2.0

quality

5.0

momentum

5.0

safety

5.0

The Lician Score is a comprehensive 1-10 rating that evaluates PHBIacross five key dimensions: Value (valuation relative to sector),Growth (revenue and earnings trajectory),Quality (profitability and balance sheet strength),Momentum (price trends and analyst sentiment), andSafety (volatility and risk metrics).

PHBI Financial Snowflake

5-axis analysis across key investment dimensions

4.4/10

Neutral

5.0

Value

Valuation vs. sector peers

2.0

Growth

Revenue & earnings trajectory

5.0

Quality

Profitability & moat strength

5.0

Momentum

Price trends & analyst sentiment

5.0

Safety

Financial stability & risk

Upcoming Events for PHBI

Dashboard

Enter a ticker to analyze